WO2005054840A1 - 血液成分の測定方法およびそれに用いるセンサならびに測定装置 - Google Patents
血液成分の測定方法およびそれに用いるセンサならびに測定装置 Download PDFInfo
- Publication number
- WO2005054840A1 WO2005054840A1 PCT/JP2004/018020 JP2004018020W WO2005054840A1 WO 2005054840 A1 WO2005054840 A1 WO 2005054840A1 JP 2004018020 W JP2004018020 W JP 2004018020W WO 2005054840 A1 WO2005054840 A1 WO 2005054840A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- electrode
- sensor
- electrode system
- blood component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/728—Bilirubin; including biliverdin
Definitions
- the present invention relates to a method for measuring blood components, a sensor used therefor, and a measuring device.
- the present invention relates to a method for measuring a blood component, a sensor used therefor, and a measuring device.
- the blood component measurement sensor has, for example, a configuration in which a cover is arranged via a spacer on an insulating substrate having a working electrode and a counter electrode formed on the surface thereof.
- a reagent containing an oxidoreductase, a mediator (electron carrier), and the like are arranged, and this portion serves as an analysis unit.
- One end of a flow path for introducing blood is communicated with the analyzer, and the other end of the flow path is open to the outside, and this serves as a blood supply port.
- the analysis of blood components using such a sensor is performed, for example, as follows. That is, first, the sensor is set in a dedicated measuring device (meter). Then, the fingertip or the like is damaged with a lancet to cause bleeding, and the blood supply port of the sensor is brought into contact therewith. Blood is sucked into the flow path of the sensor by capillary action, passes through it, and is introduced into the analysis unit, where it comes into contact with the reagent. Then, the components in the blood react with the oxidoreductase to cause an oxidation-reduction reaction, whereby an electric current flows through the mediator. This current is detected, and based on the current value, the amount of the blood component is calculated in the measuring device and displayed.
- a dedicated measuring device meter
- the fingertip or the like is damaged with a lancet to cause bleeding, and the blood supply port of the sensor is brought into contact therewith. Blood is sucked into the flow path of the sensor by capillary action, passes through it, and is introduced into the analysis
- a force capable of measuring a blood component using a sensor As the measured value may be affected by hematocrit (Hct), in order to obtain a correct measured value, It is necessary to measure the Hct value and correct the blood component amount based on this value.
- Hct hematocrit
- there is a method of measuring the Hct value using a mediator see Patent Document 2.
- Patent Document 1 Japanese Patent Publication No. 2003-501627
- Patent Document 2 Japanese Patent No. 3369183
- the present invention provides a blood component measurement method capable of sufficiently and accurately correcting the blood component amount by measuring the Hct value with high accuracy and high reliability, and a sensor and a measurement device used therefor. With the goal.
- the measurement method of the present invention provides a method in which a blood component in blood is oxidized and reduced with an oxidoreductase in the presence of a mediator, and an oxidizing current or a reducing current generated at that time is converted to an electrode system
- an electrode system having a working electrode and a counter electrode is prepared, a mediator is not arranged on the working electrode of the two electrodes, and a mediator is arranged on the counter electrode.
- the senor of the present invention is a sensor for measuring the blood component by redoxing a blood component and detecting an oxidation current or a reduction current resulting from the reaction with an electrode.
- the first analyzer has a first electrode system
- the second analyzer has a second electrode system
- the first analyzer has a first electrode system.
- An oxidoreductase having at least the blood component as a substrate and a mediator are arranged on the electrode system.
- the blood component is acidified with the oxidoreductase in the presence of the mediator.
- the first electrode system detects an oxidation current or a reduction current generated when a voltage is applied, and measures the blood component.In the second analysis unit, the second electrode system operates.
- a counter electrode, and a female electrode is provided on the working electrode of the two electrodes. Ieta not been arranged, it is arranged a mediator on the counter electrode, prior to the second electrode system
- the blood is introduced, a voltage is applied to the blood in this state, and the Hct value of the blood is measured by detecting the current value of the oxygen current or the reduction current flowing between the working electrode and the counter electrode. It is a sensor.
- the measurement device of the present invention is a blood component measurement device, comprising: holding means for holding the sensor of the present invention; means for applying a voltage to a first electrode system of the sensor; Detecting means for detecting an oxidizing current or a reducing current flowing through the first electrode system; calculating means for calculating the blood component amount from the detected current value; and a second electrode system of the sensor. Applying means for applying a voltage, means for detecting an oxidizing current or a reducing current flowing through a second electrode system of the sensor, and calculating means for calculating the detected Hct value in the blood. It is a measuring device which has.
- the present invention has a feature in the measurement of the Hct value.
- the current reflecting the Hct value can be easily detected with high precision and high reliability by arranging the mediator only at the counter electrode.
- the measurement method, sensor, and measurement device of the present invention since the amount of the blood component is corrected based on the Hct value measured with high accuracy and high reliability, a sufficient and accurate correction can be performed.
- the blood component amount value after the correction also has high accuracy and high reliability.
- FIG. 1 is an exploded perspective view showing an example of a sensor of the present invention.
- FIG. 2 is a cross-sectional view of the sensor.
- FIG. 3 is a plan view of the sensor.
- FIG. 4 is an exploded perspective view showing another example of the sensor of the present invention.
- FIG. 5 is a cross-sectional view of the sensor.
- FIG. 6 is a plan view of the sensor.
- FIG. 7A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention.
- FIG. 7B is a diagram showing a response current value (A) of the Hct measurement with respect to the application of the voltage in the example.
- FIG. 7C is a graph showing the change with time in the sensitivity difference (%) to the application of the voltage in the above example.
- FIG. 8A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention.
- FIG. 8B is a diagram showing a response current value (A) of the Hct measurement with respect to the application of the voltage in the example.
- FIG. 8C is a graph showing the change with time in the sensitivity difference (%) to the application of the voltage in the above example.
- FIG. 9A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention.
- FIG. 9B is a diagram showing a response current value (A) of the Hct measurement to the application of the voltage in the above example.
- FIG. 9C is a graph showing the change with time in the sensitivity difference (%) with respect to the application of the voltage in the above example.
- FIG. 10A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention
- FIG. 10B is a graph showing a response time value A) of the Hct measurement with respect to application of a voltage in the above example
- FIG. 10C is a graph showing the change over time in the sensitivity difference (%) with respect to the application of the voltage in the above example.
- FIG. 11A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention
- FIG. 11B is a graph showing the response current value A) of the Hct measurement to the application of voltage in the above example over time
- FIG. 11C is a graph showing the change over time in the sensitivity difference (%) with respect to the application of a voltage in the above example.
- FIG. 12A is a diagram showing an arrangement state of a reagent layer in still another example of the sensor of the present invention
- FIG. 12B is a graph showing a response time value A) of the Hct measurement with respect to application of a voltage in the above example
- FIG. 12C is a graph showing the change over time in the sensitivity difference (%) with respect to the application of a voltage in the above example.
- FIG. 13A is a diagram showing an arrangement state of a reagent layer in a sensor of a comparative example
- FIG. 13B shows a change over time of a response current value A) of Hct measurement with respect to application of a voltage in the above example
- FIG. 13C is a graph showing the change over time in the sensitivity difference (%) with respect to the application of the voltage in the above example.
- FIG. 14A is a diagram showing an arrangement state of a reagent layer in a sensor of another comparative example
- FIG. 14B is a graph showing a change over time of a response current value A) of Hct measurement with respect to application of a voltage in the above example
- FIG. 14C is a graph of the change over time in the sensitivity difference (%) with respect to the application of the voltage in the above example.
- FIG. 15A is a diagram showing an arrangement state of a reagent layer in a sensor according to still another comparative example
- FIG. 15B is a graph showing a time-dependent response current value (A) of Hct measurement to voltage application in the above example
- FIG. 15C is a graph showing the change over time of the sensitivity difference (%) with respect to the application of the voltage in the above example.
- FIG. 16A is a graph showing the change over time in the response current value A) of the Hct measurement with respect to the application of the voltage (0.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 17A is a graph showing the change over time in the response current value A) of the Hct measurement to the application of the voltage (1. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 18A is a graph showing the change over time in the response current value A) of the Hct measurement to the application of the voltage (1.5 V) in still another example of the sensor of the present invention.
- FIG. 18B is a graph showing the change over time in the response current value A) of the Hct measurement to the application of the voltage (1.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 19A is a graph showing the change over time of the response current value A) of the Hct measurement to the application of the voltage (2. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 20A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (2.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 21A is a graph showing a change over time in a response current value A) of Hct measurement with respect to application of a voltage (3. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 22A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (3.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 23A is a graph showing the change over time in the response current value ( ⁇ ) of the Hct measurement to the application of the voltage (4. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 24A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (4.5 V) in still another example of the sensor of the present invention, and FIG.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 25A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (5. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 26A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (5.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 27A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement with respect to the application of the voltage (6. OV) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 28A is a graph showing the change over time in the response current value ( ⁇ ⁇ ) of the Hct measurement to the application of the voltage (6.5 V) in still another example of the sensor of the present invention.
- FIG. 7 is a graph showing a change with time of a sensitivity difference (%) with respect to application of a voltage in the above example.
- FIG. 29 is a perspective view showing an example of the measuring device of the present invention.
- FIG. 30 is a plan view showing still another example of the sensor of the present invention.
- FIG. 31 is a plan view showing a configuration of the measuring apparatus of the above example.
- the measurement of the Hct value or the mediator in the second analysis unit is not particularly limited, and examples thereof include a ferricyanide, a p-benzoquinone, and a p-ben. Nzoquinone derivatives, phenazine methosulphate, methylene blue, phlegmene, and phagecene derivatives. Among these, ferricyanide is more preferable, and potassium ferricyanide is more preferable.
- the blending amount of the mediator is not particularly limited, and is 0.1 to 100 mM, preferably 1 to 500 mM, more preferably 10 to 200 mM per measurement or per sensor. .
- the electrode in which the Hct value is measured and the mediator of the second analysis unit is not disposed is made of a polymer material for the purpose of preventing adhesion of impurities and oxidation. Preferably it is coated.
- the polymer material include carboxymethylcellulose (CMC), hydroxyethyl cellulose, hydroxypropyl pinoresenolerose, methinoresenorelose, etinoresenolerose, ethinolexoxyethyl cellulose, and carboxyethyl cellulose.
- Polyamino acids such as polyvinyl alcohol, polyvinylpyrrolidone, and polyzine, polystyrenesulfonic acid, gelatin and its derivatives, polyacrylic acid and its salts, polymethacrylic acid and its salts, starch and its derivatives, and maleic anhydride polymers and their Salt, agarose gel and its derivation Body, etc. These may be used alone or in combination of two or more.
- the coating of the electrode with the polymer material is not particularly limited, and for example, a polymer material solution may be prepared, applied to the electrode surface, and then dried to remove the solvent in the coating film.
- the applied voltage between the working electrode and the counter electrode of the Hct value measurement and the second analysis unit is equal to or higher than a voltage at which water is electrolyzed. It is more preferably in the range of 110V, even more preferably in the range of 116V.
- a voltage higher than the voltage at which water is electrolyzed a current dependent only on hematocrit can be measured with even higher sensitivity, and is not affected by other redox substances present in the blood.
- a stable current independent of individual differences (individual differences) can be obtained.
- the application time is, for example, 0.001 to 60 seconds, preferably 0.01 to 10 seconds, and more preferably 0.01 to 5 seconds.
- the closest distance between the working electrode and the counter electrode in the measurement of the Hct value and the second analysis unit is 0.05 mm or more. .
- the distance between the electrodes is 0.05 mm or more, the reliability of the measured value is improved.
- a more preferable distance between the electrodes is 0.1 mm or more, and further preferably 0.5 mm or more.
- the correction based on the Hct value is a correction based on any of a calibration curve and a calibration table of the Hct value and the blood component amount created in advance.
- the measurement order of the blood component measurement and the Hct value measurement is not particularly limited.
- the blood components are first measured. It is preferable to measure the Hct value after the measurement. In other words, this is the case where it is used as a counter electrode in the Hct value measurement as much as possible in the blood component measurement.
- a mediator eg, potassium ferricyanide
- ferricyanide ions are predominantly present.
- the electrolytic reduction reaction at the counter electrode becomes a rate-determining process.
- the electrode system for detecting the oxidation current or the reduction current in the blood component measurement preferably includes a working electrode and a counter electrode.
- the measurement environment temperature is further measured, thereby correcting the blood component amount. Enzymatic reactions are affected by their environmental temperature.
- the correction based on the temperature is a correction based on the deviation of the calibration curve and the calibration table created in advance.
- the blood component to be measured is, for example, glucose, lactic acid, uric acid, pyrilvin, cholesterol, or the like.
- the oxidoreductase is appropriately selected according to the blood component to be measured.
- the redox enzyme include glucose oxidase, ratate oxidase, cholesterol oxidase, bilirubin oxidase, glucose dehydrogenase, ratate dehydrogenase and the like.
- the amount of the oxidoreductase is, for example, 0.01 to 100 U, preferably 0.05 to 10 U, more preferably 0.05 to 10 U per sensor or one measurement. 0.1-5U.
- glucose is preferably used as a measurement target.
- the oxidoreductase is preferably glucose oxidase or glucose dehydrogenase.
- the first electrode system has a working electrode and a counter electrode.
- any one or all of the electrodes included in the first electrode system are the same as those of the second electrode system. It is preferable to also serve as the counter electrode. More preferably, in the first electrode system and the second electrode system, only the working electrode of the first electrode system also serves as a counter electrode of the second electrode system.
- the mediator arranged on the first electrode system is not particularly limited, and examples thereof include a ferricyanide, p-benzoquinone, and p-benzoquinone. Derivatives, phenazine methosulphate, methylene blue, Hue Sen, Hue Sen Conductors. Among them, ferricyanide is more preferable, and potassium ferricyanide is more preferable.
- the blending amount of the mediator is not particularly limited, and is, for example, 0.1 lOOmOm per measurement or per sensor, preferably 1-1500mM, more preferably 10mOmM. 200 mM.
- the blood component measurement sensor of the present invention further includes an insulating substrate, on which a first analysis unit and a second analysis unit, and a flow path for introducing blood into each of the analysis units. It is preferable that one end of the flow path is opened to the outside of the sensor to serve as a blood supply port.
- the blood supply port may be one, and the flow path may be branched in the middle thereof, and an end of each branched flow path may be connected to each of the analysis units.
- the configuration may be such that the second analyzer is located in the middle of the flow path, and the first analyzer is located behind the second analyzer.
- the blood component measurement sensor of the present invention further has a spacer and a cover, and the cover is disposed on the insulating substrate via the spacer.
- a parallel configuration is preferred.
- a polymer material, an enzyme stabilizer and a crystal homogenizing agent are further arranged on the first electrode system.
- the polymer material protects the electrode surface by preventing adhesion of impurities to the electrode surface and oxidation of the electrode surface.
- the polymer material include CMC, hydroxyethyl cellulose, hydroxypropinoresenololose, methinoresenorelose, etinoresenorelose, etinole hydroxyethyl cellulose, carboxyl cellulose, polybutyl alcohol, and polybutyl alcohol.
- Polyamino acids such as burpyrrolidone and polyzine, polystyrene sulfonic acid, gelatin and its derivatives, polyacrylic acid and its salts, polymethacrylic acid and its salts, starch and its derivatives, maleic anhydride polymers and their salts, agarose gels and their And the like. These may be used alone or in combination of two or more. Among them, preferred is CMC.
- the ratio of the polymer material is, for example, 0.001 to 10% by weight, preferably 0.005 to 5% by weight, more preferably 0.005 to 5% by weight, based on the whole reagent solution for preparing the reagent portion. Is 0.01-1% by weight.
- Examples of the enzyme stabilizer include sugar alcohols.
- sugar alcohols may be used alone or in combination of two or more. Of these, preferred is maltitol.
- the amount of the enzyme stabilizer is in the range of 0.1 to 500 mM per measurement or per sensor, for example, preferably in the range of 0.5 to 100 mM, more preferably in the range of 0.5 to 100 mM. It is in the range of 50 mM.
- the crystal homogenizing agent is used to homogenize the crystal state of the reagent portion, and includes, for example, amino acids.
- the amino acids include glycine, lanine, palin, oral isine, isoleucine, serine, threonine, methionine, asparagine, glutamine, arginine, lysine, histidine, phenylalanine, tryptophan, proline, sarcosine, betaine, and taurine. And their salts, substituents and derivatives. These may be used alone or in combination of two or more. Of these, glycine, serine, proline, threonine, lysine and taurine are preferred, and more preferably taurine.
- the compounding amount of the crystal homogenizing agent is, for example, 0.1 to 1000 mM, preferably 10 to 500 mM, and more preferably 20 to 200 mM per measurement or per sensor.
- the blood component measurement sensor of the present invention further includes a blood detection electrode, and the blood detection electrode is positioned behind at least one of the analysis units from the blood supply port, It is preferable that the blood detection electrode can reliably detect that blood has been introduced into at least one of the analysis sections. More preferably, the blood detection electrode is located at the rear of each of the analysis sections.
- the measuring apparatus of the present invention further includes a correction means for correcting the blood component amount based on the Hct value.
- the voltage applied to the second electrode system is preferably a voltage equal to or higher than a value at which water is electrolyzed, more preferably in a range of 110 V, More preferably, in the range of 1-16.5V is there.
- FIG. 29 is a perspective view showing an example of the measuring apparatus of the present invention in a state where the sensor of the present invention is mounted.
- the measuring device 123 has a sensor mounting port 125 at one end, and the sensor 121 is mounted and held here.
- Reference numeral 122 denotes a sample supply port of the sensor 121.
- a display unit 124 is provided substantially at the center of the measuring device 123, and the measurement result is displayed here.
- the measurement device of the present invention preferably includes a connector, a switching circuit, a current-Z voltage conversion circuit, an AZD conversion circuit, a reference voltage source, a CPU, and a liquid crystal display (LCD).
- a voltage can be applied to the first electrode system and the second electrode system in the sensor of the present invention, and a current value flowing in both the electrode systems is detected, and the blood component is detected therefrom.
- the amount or Hct value can be calculated, and further, the blood component amount can be corrected based on the Hct value, and the corrected value can be displayed.
- the circuit configuration of the measuring device of the present invention is, for example, an example described later.
- FIG. 1, FIG. 2, and FIG. 3 show an example of the blood component measurement sensor of the present invention.
- FIG. 1 is an exploded perspective view of the sensor
- FIG. 2 is a cross-sectional view
- FIG. 3 is a plan view, and the same parts in FIG.
- the senor has three electrodes 11, 12 and 13 formed on an insulating substrate 101. These electrodes are switchable between a working electrode and a counter electrode. The surface of the electrode 13 is coated with a polymer material such as CMC.
- a reagent layer 14 is disposed on an electrode portion formed by the electrodes 11 and 12.
- the reagent layer 14 contains an oxidoreductase such as glucose dehydrogenase and a mediator, and contains, as optional components, a polymer material, an enzyme stabilizer, and a crystal homogenizer. The types and mixing ratios of these reagents are as described above.
- a cover 103 is arranged on the insulating substrate 101 via a spacer 102 except for one end (the right end in the figure).
- a flow path 15 for introducing blood to the electrode 13 and the electrodes 11 and 12 is formed.
- This flow path 15 branches from the middle Each branch end communicates with each of the electrodes, and the leading end of the flow path extends to the other end of the sensor (the left end in the figure).
- the three electrodes 11, 12, and 13 are respectively connected to leads, and these leads extend to the one end side, and the tips of the leads are exposed without being covered by the cover. I have.
- Two air vent holes 16 are formed in a portion of the cover 103 corresponding to the branch end of the flow path 15.
- the material of the insulating substrate is not particularly limited.
- PET polyethylene terephthalate
- PC polycarbonate
- polyimide (PI) are preferred, and polyethylene terephthalate (PET) is more preferred.
- the size of the insulating substrate is not particularly limited.
- the total length is 5 to 100 mm
- the width is 2 to 50 mm
- the thickness is 0.05 to 2 mm
- the total length is 7 to 50 mm
- the width is 3 to 20 mm
- the thickness is 0.1. — Lmm, more preferably 10-30 mm in total length, 3-10 mm in width, and 0.1-0.6 mm in thickness.
- the electrodes and leads on the insulating substrate are formed of a conductive layer by sputtering or vapor deposition using, for example, gold, platinum, or radium, and then formed into a specific electrode pattern by laser.
- a conductive layer by sputtering or vapor deposition using, for example, gold, platinum, or radium, and then formed into a specific electrode pattern by laser.
- the laser for example, a YAG laser, a CO laser, an excimer laser, or the like can be used.
- the electrode pattern for example, a YAG laser, a CO laser, an excimer laser, or the like can be used.
- the surface of the electrode 13 can be coated, for example, by preparing a solution of a polymer material, dropping or coating the solution on the electrode surface, and then drying. Drying includes, for example, natural drying, air drying, hot air drying, and heat drying.
- the reagent section 14 is prepared, for example, by adding PQQ-GDH to an aqueous solution of 0.01-2.
- the material of the spacer is not particularly limited, and for example, the same material as that of the insulating substrate can be used.
- the size of the spacer is not particularly limited.
- the overall length is 5 to 100 mm
- the width is 2 to 50 mm
- the thickness is 0.01 to lmm
- the overall length is 7 to 50 mm
- the width is 3 to 20 mm.
- the thickness is 0.05 to 0.5 mm, and more preferably, the total length is 10 to 30 mm
- the width is 3 to 10 mm
- the thickness is 0.05 to 0.25 mm.
- the spacer has a T-shaped notch formed as a flow path for blood introduction.
- the force is, for example, 0.5 mm to the blood supply Loca branch.
- This notch may be formed by, for example, drilling with a laser or a drill, or may be formed using a mold that can form the notch when forming the spacer. .
- the material of the cover is not particularly limited, and for example, the same material as that of the insulating substrate can be used. It is more preferable that the portion of the cover corresponding to the ceiling of the sample supply path is subjected to a hydrophilic treatment.
- the hydrophilic treatment include a method of applying a surfactant and a method of introducing a hydrophilic functional group such as a hydroxyl group, a carbonyl group or a carboxyl group into the cover surface by plasma treatment or the like.
- the size of the cover is not particularly limited.
- the total length is 5 to 100 mm
- the width is 3 to 50 mm
- the thickness is 0.01 to 0.5 mm
- the total length is preferably 10 to 50 mm
- the width is 3 to 20 mm
- the thickness is 3 to 20 mm. It is 0.05-0.25 mm, more preferably 15-30 mm in total length, 5-10 mm in width, and 0.05-0.2 mm in thickness.
- the cover preferably has a shape in which air vent holes are formed, for example, a circle, an ellipse, a polygon, and the like, and its size is, for example, a maximum diameter of 0.01 to 10 mm, preferably, The maximum diameter is 0.025-5 mm, more preferably the maximum diameter is 0.025-2 mm.
- This air vent is made by, for example, laser or drill. It may be formed by using a mold that can form an air vent when forming the cover. Next, this sensor can be manufactured by laminating an insulating substrate, a spacer, and a cover in this order, and integrally forming them. For integration, the above three members may be attached with an adhesive, or may be heat-sealed.
- the adhesive for example, an epoxy-based adhesive, an acrylic-based adhesive, a polyurethane-based adhesive, a thermosetting adhesive (such as a hot melt adhesive), a UV-curable adhesive, or the like can be used.
- the blood sugar level measurement using this sensor is performed, for example, as follows. That is, first, a fingertip or the like is punctured with a dedicated lancet to cause bleeding. On the other hand, the sensor is set in a dedicated measuring device (meter). Then, the blood supply port of the sensor set in the measuring device is brought into contact with the bleeding blood, and blood is introduced into the sensor by capillary action. The analysis by the sensor is performed in the following steps.
- a voltage is applied between the electrodes 11 and 13, and the introduction of blood is detected by a change in current value accompanying the introduction of blood. After confirming the introduction of blood, the following steps are started.
- the applied voltage in step 1 is, for example, 0.05-IV.
- the electrode 11 After reacting Darcos in the blood with Darcos acid oxidase reductase for a certain period of time, the electrode 11 is used as a working electrode, the electrode 12 is used as a counter electrode, and a voltage is applied to the two electrodes.
- the mediator in the reduced state generated above is oxidized, and the oxidation current is detected.
- the reaction time between the glucose and the acid reductase is, for example, 0 to 60 seconds, preferably 0.5 to 30 seconds, and more preferably 110 seconds.
- the applied voltage and the applied time in Step 2 are, for example, 0.05-IV, preferably 0.1-0.8 V, more preferably 0.2-0.5 V. 0.01 to 30 seconds, preferably 0.1 to 10 seconds, more preferably 115 seconds.
- a current depending on the Hct value based on the electrolytic oxidation reaction of blood components can be detected.
- the conversion of the detected current value into the Hct value can be performed by obtaining a calibration curve or a calibration curve table in advance. In this correction, the current and the Hct value created in advance
- the Hct value obtained from the calibration curve may be used, or the detected current may be used as it is.
- the applied voltage and the applied time in Step 3 are, for example, 110 V, preferably 16.5 V, more preferably 2-3 V, and the applied time is, for example, 0.001-60 seconds, preferably 0. 01-10 seconds, more preferably 0.01-1-5 seconds.
- step 3 is preferably performed after the end of step 2.
- the counter electrode can also be measured by using the force electrode 12 as the electrode 11 in this example as the counter electrode. Both electrodes 11 and 12 may be used as counter electrodes. The measurement can be performed even when the surface of the electrode 13 is not coated with a polymer material or the like.
- the corrected glucose amount is displayed or stored on the measuring device. As described above, the glucose amount may be corrected using the current depending on the Hct value detected in step 3 instead of correcting the glucose amount after obtaining the Hct value.
- FIGS. 4, 5, and 6 show other examples of the blood component measurement sensor of the present invention.
- FIG. 4 is an exploded perspective view of the sensor
- FIG. 5 is a cross-sectional view
- FIG. 6 is a plan view, and in FIG. You.
- this sensor has four electrodes 21, 22, 23 and 24 formed on an insulating substrate 201. These electrodes are switchable between a working electrode and a counter electrode. The surface of the electrode 24 is coated with the polymer material as described above.
- a reagent layer 25 is disposed on an electrode portion formed by the electrodes 21, 22, and 23.
- the reagent layer 25 contains a redox enzyme such as glucose dehydrogenase and a mediator, and contains, as optional components, a polymer material, an enzyme stabilizer and a crystal homogenizer. The types and mixing ratios of these reagents are as described above.
- One end (right end in the figure) is left on the insulating substrate 201.
- a cover 203 is arranged via a spacer 202.
- a flow path 26 for introducing blood into the reagent section 25 is formed.
- the flow path 26 is straight (I-shaped), and the front end of the flow path extends to the other end of the sensor (the left end in the figure). It is a mouth.
- the four electrodes are arranged in series in the flow channel, and the electrode 22 is located rearmost from the blood supply port side.
- the four electrodes 21, 22, 23, and 24 are respectively connected to leads, and these leads extend to the one end, and the tips of the leads are exposed without being covered by the cover. I have.
- An air vent hole 27 is formed in a portion of the cover 203 corresponding to the rear of the flow path 26.
- the material, size, and the like of the insulating substrate are not particularly limited, and are the same as in Example 1.
- the electrode, lead, coating of the electrode surface with a polymer material, and the reagent portion are also the same as in Example 1.
- the material, size, and processing method of the spacer are the same as those in the first embodiment.
- an I-shaped notch portion serving as a flow path for blood introduction is formed.
- the force is, for example, 0.5 to 50 mm in overall length and 0.1 in width. It has a total length of 1 to 10 mm and a width of 0.2 to 3 mm, more preferably a total length of 11 to 5 mm and a width of 0.5 to 2 mm.
- This notch may be formed by, for example, drilling with a laser or a drill, or may be formed using a mold that can form the notch when forming the spacer. .
- the material and size of the cover, the hydrophilic treatment, and the air vent hole are also the same as those in the first embodiment.
- the method for manufacturing the sensor of this example is the same as that of the first embodiment.
- Blood glucose measurement using this sensor is performed, for example, as follows. That is, first, a fingertip or the like is punctured with a dedicated lancet to cause bleeding. On the other hand, the sensor is set in a dedicated measuring device (meter). Then, the blood supply port of the sensor set in the measuring device is brought into contact with the bleeding blood, and blood is introduced into the sensor by capillary action. The analysis by the sensor is performed in the following steps.
- the configuration device By applying a voltage between the electrodes 24 and 22, it is detected whether blood has been introduced to the end of the flow path. After confirming that blood has been introduced to the end of the flow channel, start the subsequent steps. If the sample is not introduced to the end of the flow channel, the sample volume will be insufficient, The configuration device will display an error.
- the applied voltage in step 1 is, for example, 0.05-IV. In this case, the specimen can be detected by detecting a change in current between the electrode 22 and any other electrode (21, 23, 24).
- a voltage is applied to both electrodes with electrode 21 as the working electrode and electrode 23 as the counter electrode, and the electrode 21 is reacted by the enzyme reaction.
- the reduced mediator generated above is oxidized and its oxidation current is detected.
- the reaction time between the glucose and the acid reductase is, for example, 0 to 60 seconds, preferably 0.5 to 30 seconds, and more preferably 110 seconds.
- the applied voltage and the applied time in Step 2 are, for example, 0.05-IV, preferably 0.1-0.8 V, more preferably 0.2-0.5 V. 0.01 to 30 seconds, preferably 0.1 to 10 seconds, more preferably 115 seconds.
- the applied voltage and the applied time in step 3 are, for example, 110 V, preferably 1-6.5 V, more preferably 2-3 V, and the applied time is, for example, 0.001-60 seconds, preferably 0.01 to 10 seconds, more preferably 0.01 to 5 seconds.
- this step no mediator is disposed on the electrode 24, which is the working electrode, and there is a certain gap between the electrode 24 and the electrode 21. Since there is only the Hc value, the oxidation current depending on the Hct value can be detected without being affected by the reagent.
- This step 3 is preferably performed after the completion of step 2.
- the force acting as the counter electrode with the electrode 21 alone is not limited to this.
- the electrode 23 alone, the electrode 22 alone, the combination of the electrode 21 and the electrode 22, the combination of the electrode 21 and the electrode 23, A combination of the electrode 22 and the electrode 23 and a combination of the electrode 21 and the electrode 22 and the electrode 23 may be used as counter electrodes.
- the surface of the electrode 13 is not covered with a polymer material or the like, Even so, measurement is possible.
- the corrected glucose amount is displayed or stored on the measuring device.
- the reagent layer was prepared by dissolving potassium ferricyanide (amount: 60 mM) and taurine (80 mM) in a CMC aqueous solution (0.1 wt%), dripping it on the electrode, and then drying it. .
- the distance between the working electrode and the counter electrode was 0.1 mm or more.
- three types of blood samples with Hct values adjusted by 25, 45 and 65 were prepared. With respect to these three blood samples, the current flowing through the two electrodes of each sensor was measured under the conditions of an applied voltage of 2.5 V and an application time of 3 seconds by the sensors, and the response current value and the sensitivity in the measurement of the Hct value were measured. The difference was measured.
- FIGS. 7 to 15. 7 to 15, FIG. A is a diagram showing an arrangement pattern of the reagent layer 25, and FIG. B is a graph showing a change over time of a response current value ( ⁇ ) with respect to an applied voltage (V).
- FIG. C is a graph showing the change with time of the sensitivity difference (%) with respect to the applied voltage), and the same parts as those in FIGS.
- the reagent layer 25 is arranged so as to protrude from the counter electrode 21 for Hct measurement, and on the surface of the counter electrode 21 and between the two electrodes for blood component measurement.
- the reagent layer 25 exists on a part of the counter electrode side.
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 7B and 7C.
- the sensitivity difference did not depend on the voltage application time, and the response current reflecting the Hct value could be clearly and satisfactorily detected.
- the reagent layer 25 is disposed only on the surface of the counter electrode 21.
- the results of measuring the current flowing through the working electrode 24 and the counter electrode 21 of this sensor are shown in the graphs of FIGS. 8B and 8C.
- the difference in sensitivity did not depend on the voltage application time, and the response current reflecting the Hct value could be clearly and satisfactorily detected.
- the reagent layer 25 is disposed so as to protrude from the counter electrode 21, and the reagent layer 25 exists on the surface of the counter electrode 21 and between the two electrodes. .
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 9B and 9C. As shown in both figures, according to this sensor, the difference in sensitivity did not depend on the voltage application time, and the response current reflecting the Hct value could be clearly detected.
- the arrangement of the working electrode 24 for Hct measurement and the counter electrode 21 are exchanged, and the reagent layer 25 is provided on the surface of the counter electrode 21 and the two electrodes for measuring the blood component. It is formed on a part of the counter electrode side between the poles.
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 10B and 10C.
- the difference in sensitivity did not depend on the voltage application time, and the response current that reflected the Hct value could be clearly detected.
- the sensitivity difference was slightly smaller than in the examples of (3-2) and (3-3).
- the reagent layer 25 is disposed so as to protrude from the counter electrode 21, and the reagent layer 25 is provided on a part of the surface of the counter electrode 21 and a part between the electrodes. 25 exist Are there.
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 11B and 11C.
- the response current reflecting the Hct value can be clearly detected for one second (between 3 and 4 seconds in the figure) immediately after the voltage is applied.
- the reagent layer 25 is arranged so as to protrude from the counter electrode 21, and the reagent layer 25 exists on a part of the surface of the counter electrode 21. There is no redox substance between the electrodes.
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 12B and 12C.
- the response current reflecting the Het value is clearly detected for one second (between 3 and 4 seconds in the figure) immediately after the voltage is applied. Was completed.
- the reagent layer 25 is disposed on the working electrode 24, the counter electrode 21, and between the two electrodes.
- the results of measuring the current flowing between the two electrodes of this sensor are shown in the graphs of FIGS. 13B and 13C. As shown in both figures, this sensor could not clearly detect the response current reflecting the Hct value.
- the reagent layer 25 is disposed on each of the working electrode 24 and the counter electrode 21, and the reagent layer 25 is also located at a part between the electrodes. You. The results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 14B and 14C. As shown in both figures, this sensor could not clearly detect the response current reflecting the Hct value.
- the reagent layer 25 is not provided.
- the results of measuring the current flowing through both electrodes of this sensor are shown in the graphs of FIGS. 15B and 15C. As shown in both figures, this sensor could not detect a response current reflecting the Hct value.
- Example 4 In this example, the response current and the sensitivity difference in the Hct measurement were measured while changing the applied voltage in the range of 0.5 to 6.5 V. Measurement of the specimen (blood) and glucose, and correction of blood components were performed in the same manner as in Example 2. The sensor used for this measurement was manufactured in the same manner as in Example 3. The reagent layer 25 was placed on the counter electrode 21 and was not placed on the working electrode 24 (see FIG. 7A). In addition, the measurement of the response current value and the sensitivity difference was performed in the same manner as in Example 3. The measurement results are shown in the graphs of FIGS. 16 to 28. In Fig. 16 and Fig. 28, Fig. A is a graph showing the change over time of the response current value A) with respect to the applied voltage). It is.
- a response current reflecting the Hct value could be detected even with an applied voltage of 0.5V, but when applied at 1-6.5V, the response current shown in Figs.
- the response current can be detected more clearly, and the most preferable is the case where the voltage is applied at 11 to 13 V as shown in FIGS.
- the current based on the Hct value is detected by changing the applied voltage under a certain condition, but the present invention is not limited to this, and the applied voltage is not in the range shown in the present embodiment.
- the response current reflecting the Hct value can be clearly detected by appropriately setting other conditions such as the distance between the electrodes and the type and amount of the redox substance. The component amount can be corrected.
- FIG. 30 is a plan view showing still another example of the sensor of the present invention.
- This sensor has an electrode pattern that is different from the electrode pattern of the sensor shown in Embodiments 14 to 14 described above.
- the sensor has two electrodes 111 and 112 constituting a second analysis unit for Hct measurement on the insulating substrate on the upstream side of the blood flow, and further on the downstream side. It has two electrodes 113 and 114 that constitute a first analyzer for blood component measurement.
- a reagent layer (not shown) is arranged in each of the first analysis section and the second analysis section.
- the reagent layer disposed in the first analysis section contains an acid-reducing enzyme such as glucose dehydrogenase and a mediator, and includes, as optional components, a polymer material, an enzyme stabilizer, and a crystallite.
- the composition includes a qualifying agent, and its arrangement is not particularly limited.
- the reagent layer arranged in the second analysis section contains a mediator, and contains a polymer material as an optional component.
- the reagent layer is disposed only on the counter electrode.
- the sensor is the same as the sensor exemplified in the first or second embodiment.
- FIG. 31 shows an example of the configuration of the measuring apparatus of the present invention.
- This measuring device can be equipped with, for example, the sensor described in the second embodiment.
- the measurement device 130 includes four connectors 137a-137d, a switching circuit 136, a current-Z voltage conversion circuit 135, an AZD conversion circuit 134, a reference voltage source 133, a CPU 131, and a liquid crystal display (LCD) 132. It is a major component.
- the reference voltage source 133 may be a ground.
- Each electrode 21, 22, 23, 24 of the sensor is connected to a current-Z voltage conversion circuit 135 and a reference voltage source 133 via connectors 137 a-137 d and a switching circuit 136.
- the current-Z voltage conversion circuit 135 is connected to the CPU 131 via the AZD conversion circuit 134!
- the measurement of the blood component amount is performed, for example, as follows.
- the switching circuit 136 is connected to the current-Z voltage conversion circuit 135 via the electrode 21 serving as a working electrode for measuring the amount of blood components via the force connector 137a, and detects the introduction of blood.
- Electrode 22 serving as a detection electrode for the connection is connected to a reference voltage source 133 via a connector 137b.
- This current is converted to a voltage by a current-Z voltage conversion circuit 135, and the voltage value is converted to a digital value by an AZD conversion circuit 134 and output to the CPU 131.
- CPU 131 detects that blood has been introduced based on the digital value.
- the amount of the blood component is measured.
- the measurement of the blood component amount is performed as follows. First, in response to a command from the CPU 131, the electrode 21 serving as a working electrode for measuring the blood component amount is connected to the current Z-voltage conversion circuit 135 via the connector 137a by the switching circuit 136, and the switching circuit 136 measures the blood component amount.
- the electrode 23 serving as a counter electrode is connected to the reference voltage source 133 via the connector 137c.
- the current-Z voltage conversion circuit 135 and the reference voltage source 133 are turned off, and after a certain period of time, the CPU 131 According to the command, a constant voltage is applied between the electrodes 21 and 23. A current flows between the electrodes 21 and 23, and this current is converted to a voltage by a current-Z voltage conversion circuit 135, and the voltage value is converted to a digital value by an AZD conversion circuit 134 and output to the CPU 131. You. The CPU 131 converts the digital value into a blood component amount.
- the Hct value is measured.
- the measurement of the Hct value is performed, for example, as follows. First, in response to a command from the CPU 131, the switching circuit 136 connects the electrode 24 serving as a working electrode for measuring the Hct value to the current-Z voltage conversion circuit 135 via the connector 137d, and the counter electrode for measuring the Hct value.
- the electrode 21 is connected to a reference voltage source 133.
- a constant voltage is applied between the electrodes 24 and 21 from the current Z voltage conversion circuit 135 and the reference voltage source 133.
- the current flowing between the electrodes 24 and 21 is converted into a voltage by a current Z voltage conversion circuit 135, and the voltage value is converted into a digital value by an AZD conversion circuit 134 and output to the CPU 131.
- the CPU 131 converts the digital value into an Hct value.
- the present invention has been described with reference to the example of measuring glucose, but the present invention is not limited to this.
- the power described above The present invention is also useful for measuring other blood components such as lactic acid and cholesterol.
- the measurement method and the sensor according to the present invention can obtain a current response according to the type of the sample introduced into the sensor, and can thus determine the type of the sample based on the result. Therefore, the measurement method and the sensor of the present invention can easily determine, for example, a standard solution for sensor calibration, plasma, and blood.
- the blood component measurement method of the present invention can measure the Hct value with high accuracy and high reliability electrochemically and easily, and can correct the blood component amount based on this. Therefore, the measurement method, sensor, and measurement device of the present invention can be preferably used in all fields of measuring blood components such as biology, biochemistry, and medicine, and are particularly suitable for the field of clinical testing.
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/578,275 US8535497B2 (en) | 2003-12-04 | 2004-12-03 | Method of measuring blood component, sensor used in the method, and measuring device |
EP17211212.0A EP3399047A1 (en) | 2003-12-04 | 2004-12-03 | A biosensor |
JP2005515983A JP4611208B2 (ja) | 2003-12-04 | 2004-12-03 | 血液成分の測定方法およびそれに用いるセンサならびに測定装置 |
CA2548440A CA2548440C (en) | 2003-12-04 | 2004-12-03 | Method of measuring blood component, sensor used in the method, and measuring device |
EP04819924.4A EP1691192B1 (en) | 2003-12-04 | 2004-12-03 | Blood component measuring method |
KR1020067011240A KR101117332B1 (ko) | 2003-12-04 | 2006-06-08 | 혈액 성분의 측정 방법 및 그것에 이용하는 센서 및 측정장치 |
US12/829,077 US8540864B2 (en) | 2003-12-04 | 2010-07-01 | Method of measuring blood component, sensor used in the method, and measuring device |
US13/972,389 US9213012B2 (en) | 2003-12-04 | 2013-08-21 | Method of measuring blood component, sensor used in the method, and measuring device |
US14/939,281 US9719956B2 (en) | 2003-12-04 | 2015-11-12 | Method of measuring blood component, sensor used in the method, and measuring device |
US15/634,548 US20170292929A1 (en) | 2003-12-04 | 2017-06-27 | Method of measuring blood component, sensor used in the method, and measuring device |
US15/860,190 US20180128769A1 (en) | 2003-12-04 | 2018-01-02 | Method of measuring blood component, sensor used in the method, and measuring device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003405480 | 2003-12-04 | ||
JP2003-405480 | 2003-12-04 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/578,275 A-371-Of-International US8535497B2 (en) | 2003-12-04 | 2004-12-03 | Method of measuring blood component, sensor used in the method, and measuring device |
US12/829,077 Division US8540864B2 (en) | 2003-12-04 | 2010-07-01 | Method of measuring blood component, sensor used in the method, and measuring device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005054840A1 true WO2005054840A1 (ja) | 2005-06-16 |
Family
ID=34650218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/018020 WO2005054840A1 (ja) | 2003-12-04 | 2004-12-03 | 血液成分の測定方法およびそれに用いるセンサならびに測定装置 |
Country Status (7)
Country | Link |
---|---|
US (6) | US8535497B2 (ja) |
EP (4) | EP3399047A1 (ja) |
JP (1) | JP4611208B2 (ja) |
KR (1) | KR101117332B1 (ja) |
CN (1) | CN100472210C (ja) |
CA (1) | CA2548440C (ja) |
WO (1) | WO2005054840A1 (ja) |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1746413A2 (en) | 2005-07-19 | 2007-01-24 | Hypoguard Limited | Electrochemical Biosensor and method of manufacture |
WO2007120149A1 (en) * | 2006-04-18 | 2007-10-25 | Home Diagnostics, Inc. | Biosensors comprising heat sealable spacer materials |
WO2007123179A1 (ja) * | 2006-04-19 | 2007-11-01 | Panasonic Corporation | バイオセンサ |
WO2008013224A1 (fr) * | 2006-07-26 | 2008-01-31 | Panasonic Corporation | Système de mesure de biocapteur et procédé de mesure |
WO2008047843A1 (en) * | 2006-10-19 | 2008-04-24 | Panasonic Corporation | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
WO2008047842A1 (fr) * | 2006-10-19 | 2008-04-24 | Panasonic Corporation | Procédé de mesure de valeur hématocrite de prélèvement sanguin, procédé de mesure de concentration d'analyte dans un prélèvement sanguin, puce de capteur et unité de détection |
US20090038939A1 (en) * | 2007-04-18 | 2009-02-12 | Natasha Popovich | System and methods of chemistry patterning for a multiple well biosensor |
JP2009510405A (ja) * | 2005-09-27 | 2009-03-12 | アボット ダイアベティス ケア インコーポレイテッド | インビトロ被検体センサおよびその使用方法 |
JPWO2007123178A1 (ja) * | 2006-04-19 | 2009-09-03 | パナソニック株式会社 | バイオセンサ |
WO2010095442A1 (ja) | 2009-02-18 | 2010-08-26 | パナソニック株式会社 | 穿刺器具、生体試料測定装置及び生体試料測定システム |
JP2011075362A (ja) * | 2009-09-30 | 2011-04-14 | Arkray Inc | 赤血球含有試料における目的成分の測定方法 |
US8057404B2 (en) | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
US8430999B2 (en) * | 2005-09-02 | 2013-04-30 | Arkray, Inc. | Method for detecting sample supply condition, and analyzer |
JP2013145243A (ja) * | 2006-09-22 | 2013-07-25 | Bayer Healthcare Llc | 改善された安定性およびヘマトクリット性能(performance)を有するバイオセンサー系 |
WO2013157263A1 (ja) * | 2012-04-19 | 2013-10-24 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
WO2013168390A1 (ja) * | 2012-05-07 | 2013-11-14 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
WO2013183215A1 (ja) * | 2012-06-06 | 2013-12-12 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
US8760178B2 (en) | 2009-09-30 | 2014-06-24 | Arkray, Inc. | Method for measuring target component in erythrocyte-containing specimen |
JP2014232102A (ja) * | 2013-05-02 | 2014-12-11 | アークレイ株式会社 | 測定装置、及び測定方法 |
CN104407025A (zh) * | 2014-11-19 | 2015-03-11 | 东莞市青麦田数码科技有限公司 | 一种电化学传感器及其制备方法 |
JP2015052608A (ja) * | 2005-09-30 | 2015-03-19 | バイエル・ヘルスケア・エルエルシー | ゲート化ボルタンメトリー |
JP2015111115A (ja) * | 2013-11-08 | 2015-06-18 | アークレイ株式会社 | 測定装置、及び測定方法 |
JP2015139376A (ja) * | 2014-01-27 | 2015-08-03 | 東洋紡株式会社 | グルコースデヒドロゲナーゼ組成物 |
JP2016510901A (ja) * | 2013-03-14 | 2016-04-11 | バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC | 保護層を用いた製造中における電極機能の維持 |
JP2017009550A (ja) * | 2015-06-26 | 2017-01-12 | 国立研究開発法人産業技術総合研究所 | バイオセンサ |
JPWO2015004900A1 (ja) * | 2013-07-08 | 2017-03-02 | パナソニックヘルスケアホールディングス株式会社 | 血液成分の測定装置、血液成分の測定方法 |
JP2017531785A (ja) * | 2014-10-27 | 2017-10-26 | シラグ・ゲーエムベーハー・インターナショナルCilag GMBH International | 拡散を測定するための方法 |
US9846136B2 (en) | 2007-09-24 | 2017-12-19 | Ascensia Diabetes Care Holdings Ag | Multi-region and potential test sensors, methods and systems |
WO2018097214A1 (ja) * | 2016-11-25 | 2018-05-31 | パナソニックヘルスケアホールディングス株式会社 | 生体試料の成分を測定する方法 |
JP2019035748A (ja) * | 2017-08-17 | 2019-03-07 | アークレイ株式会社 | 測定方法、及び測定装置 |
JP2019144133A (ja) * | 2018-02-21 | 2019-08-29 | 国立研究開発法人産業技術総合研究所 | アッセイ装置 |
US10842427B2 (en) | 2005-09-30 | 2020-11-24 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US10948442B2 (en) | 2017-10-18 | 2021-03-16 | Renesas Electronics Corporation | Impedance measuring semiconductor circuit and blood-sugar level meter |
US11002743B2 (en) | 2009-11-30 | 2021-05-11 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11045125B2 (en) | 2008-05-30 | 2021-06-29 | Intuity Medical, Inc. | Body fluid sampling device-sampling site interface |
US11051734B2 (en) | 2011-08-03 | 2021-07-06 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
JP2021530695A (ja) * | 2018-07-13 | 2021-11-11 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | マイクロアルブミンクレアチニンアッセイ検出フラグおよびそれに関連する製造および使用方法 |
US11399744B2 (en) | 2008-06-06 | 2022-08-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US11419532B2 (en) | 2005-06-13 | 2022-08-23 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
DE602004028463D1 (de) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | Verfahren und vorrichtung zur injektion von flüssigkeit |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | METHOD AND APPARATUS PROVIDING A VARIABLE USER INTERFACE |
CA2543010A1 (en) | 2003-10-24 | 2005-05-06 | Bayer Healthcare Llc | Enzymatic electrochemical biosensor |
WO2005054839A1 (ja) * | 2003-12-04 | 2005-06-16 | Matsushita Electric Industrial Co., Ltd. | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
CN100472210C (zh) | 2003-12-04 | 2009-03-25 | 松下电器产业株式会社 | 血液成分的测定方法及该方法中使用的传感器和测定装置 |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
WO2005103669A1 (ja) * | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
EP1751532A1 (en) * | 2004-05-14 | 2007-02-14 | Bayer Healthcare, LLC | Methods for performing hematocrit adjustment in glucose assays and devices for same |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
CA2640969C (en) * | 2006-01-31 | 2011-12-13 | Matsushita Electric Industrial Co. Ltd. | Blood sensor and blood test apparatus having the same |
US7749766B2 (en) * | 2007-01-12 | 2010-07-06 | Nova Biomedical Corporation | Bilirubin sensor |
EP1985994A1 (en) * | 2007-04-27 | 2008-10-29 | Radiometer Medical ApS | An optical sensor system |
EP2193367B1 (en) | 2007-09-27 | 2019-01-23 | Philosys CO., LTD. | Method for correcting erroneous results of measurement in biosensors and apparatus using the same |
WO2009076433A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Reagents and methods for detecting analytes |
JP2009250806A (ja) * | 2008-04-07 | 2009-10-29 | Panasonic Corp | バイオセンサシステム、センサチップおよび血液試料中の分析物濃度の測定方法 |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
KR100972108B1 (ko) * | 2008-07-09 | 2010-07-26 | 주식회사 올메디쿠스 | 바이오센서 |
CN102209893B (zh) * | 2008-11-28 | 2013-06-26 | 松下电器产业株式会社 | 传感器芯片、生物传感器系统、生物试样的温度测定方法、血液试样的温度测定方法、血液试样中的分析物的浓度测定方法 |
US9289168B2 (en) * | 2008-12-29 | 2016-03-22 | Medtronic Minimed, Inc. | System and/or method for glucose sensor calibration |
JP4876186B2 (ja) * | 2009-01-30 | 2012-02-15 | パナソニック株式会社 | 生体試料の温度測定方法、生体試料の濃度測定方法、センサチップおよびバイオセンサシステム |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
EP2636751A3 (de) * | 2009-03-20 | 2013-12-18 | Roche Diagniostics GmbH | Verfahren zum Bestimmen einer Körperflüssigkeit |
KR101104400B1 (ko) * | 2009-06-02 | 2012-01-16 | 주식회사 세라젬메디시스 | 생체물질을 측정하는 바이오센서 |
KR101104398B1 (ko) * | 2009-06-02 | 2012-01-16 | 주식회사 세라젬메디시스 | 생체물질을 측정하는 장치 및 그 제조 방법 |
KR101100620B1 (ko) * | 2009-06-04 | 2012-01-03 | 주식회사 인포피아 | 재현성 향상을 위한 알고리즘을 사용하는 생체 데이터 측정장치 및 생체 데이터 측정방법 |
WO2011013694A1 (ja) * | 2009-07-28 | 2011-02-03 | パナソニック電工株式会社 | 血糖値推定装置 |
KR101022837B1 (ko) * | 2009-08-13 | 2011-03-18 | 에스디 바이오센서 주식회사 | 센서 특성을 저항으로 나타내는 센서 스트립 및 이를 이용한 오토코딩방법 |
KR101022838B1 (ko) * | 2009-10-06 | 2011-03-18 | 에스디 바이오센서 주식회사 | 오토코딩용 저항전극을 구비한 센서 스트립을 채용하는 혈당측정장치 |
US8101065B2 (en) | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
US8877034B2 (en) | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8932445B2 (en) | 2010-09-30 | 2015-01-13 | Cilag Gmbh International | Systems and methods for improved stability of electrochemical sensors |
US8617370B2 (en) | 2010-09-30 | 2013-12-31 | Cilag Gmbh International | Systems and methods of discriminating between a control sample and a test fluid using capacitance |
JP5953301B2 (ja) * | 2011-06-16 | 2016-07-20 | パナソニックヘルスケアホールディングス株式会社 | センサおよびこれを備えたセンサシステム |
GB201113880D0 (en) * | 2011-08-12 | 2011-09-28 | Archimed Llp | Novel compositions |
CN104024841B (zh) * | 2011-09-15 | 2017-03-08 | 株式会社Ndd | 糖化蛋白质检测传感器以及具备该传感器的便携式糖化蛋白质检测装置 |
US8623660B2 (en) * | 2011-09-30 | 2014-01-07 | Lifescan Scotland Limited | Hand-held test meter with phase-shift-based hematocrit measurement circuit |
US8870763B2 (en) * | 2011-10-26 | 2014-10-28 | Medtronic Minimed, Inc. | Method and/or system for multicompartment analyte monitoring |
WO2013072275A1 (de) * | 2011-11-14 | 2013-05-23 | Roche Diagnostics Gmbh | Analaysegerät zum nachweis mindestens eines analyten in einer probe |
WO2013073072A1 (ja) * | 2011-11-18 | 2013-05-23 | 株式会社村田製作所 | ヘマトクリット値の測定方法およびこの測定方法を用いた定量分析方法並びにセンサチップ |
WO2013105678A1 (ko) * | 2012-01-11 | 2013-07-18 | 경원대학교 산학협력단 | 혈당측정유니트, 이를 포함하는 혈당측정시스템 및 혈당측정방법 |
KR101466222B1 (ko) * | 2012-06-01 | 2014-12-01 | 주식회사 아이센스 | 정확도가 향상된 전기화학적 바이오센서 |
TWI547687B (zh) * | 2012-06-13 | 2016-09-01 | 達爾生技股份有限公司 | 血液樣本之血糖值的校正方法及其校正系統 |
US8877023B2 (en) * | 2012-06-21 | 2014-11-04 | Lifescan Scotland Limited | Electrochemical-based analytical test strip with intersecting sample-receiving chambers |
WO2014083858A1 (ja) * | 2012-11-28 | 2014-06-05 | パナソニック株式会社 | 生体情報測定装置、バイオセンサシステム、及び生体情報測定装置のエラー検知方法 |
TWI493186B (zh) * | 2013-02-08 | 2015-07-21 | Hmd Biomedical Inc | 檢測試片、檢測裝置及檢測方法 |
US9523653B2 (en) | 2013-05-09 | 2016-12-20 | Changsha Sinocare Inc. | Disposable test sensor with improved sampling entrance |
GB2514846B (en) * | 2013-06-07 | 2015-09-30 | Lifescan Scotland Ltd | Electrochemical-based analytical test strip with a soluble electrochemically-active coating opposite a bare electrode |
CN105793700B (zh) | 2013-11-27 | 2018-09-28 | 普和希控股公司 | 血液成分量的测定方法 |
US9518951B2 (en) | 2013-12-06 | 2016-12-13 | Changsha Sinocare Inc. | Disposable test sensor with improved sampling entrance |
US9897566B2 (en) | 2014-01-13 | 2018-02-20 | Changsha Sinocare Inc. | Disposable test sensor |
US9939401B2 (en) | 2014-02-20 | 2018-04-10 | Changsha Sinocare Inc. | Test sensor with multiple sampling routes |
US20150276650A1 (en) * | 2014-03-28 | 2015-10-01 | Broadmaster Biotech Corp. | Method for fast measurement of specimen concentration |
US9897567B2 (en) * | 2014-06-25 | 2018-02-20 | Delbio, Inc. | Detection method for detecting blood glucose and hemoglobin of blood sample |
TWI531789B (zh) * | 2014-06-25 | 2016-05-01 | 達爾生技股份有限公司 | 血液樣本之血糖值的校正方法 |
US9903832B2 (en) | 2015-04-28 | 2018-02-27 | Industrial Technology Research Institute | Methods for measuring analyte concentration |
JP6576170B2 (ja) * | 2015-09-02 | 2019-09-18 | 旭化成ファーマ株式会社 | くし型電極を用いた糖化タンパク質の測定方法 |
US11255834B2 (en) | 2016-03-22 | 2022-02-22 | Conductive Technologies, Inc. | Physical characteristic determination of a biological sample |
US20190056345A1 (en) * | 2017-08-16 | 2019-02-21 | Tyson Bioresearch Inc. | Method of operation of a meter |
CN109406591A (zh) | 2017-08-17 | 2019-03-01 | 爱科来株式会社 | 测定方法和测定装置 |
CN109406598A (zh) * | 2017-08-17 | 2019-03-01 | 爱科来株式会社 | 测定方法以及测定装置 |
US10636722B2 (en) * | 2017-09-26 | 2020-04-28 | Western Digital Technologies, Inc. | System and method to enhance solder joint reliability |
EP3770594A4 (en) * | 2018-03-19 | 2021-05-05 | PHC Holdings Corporation | METHOD OF MEASURING THE AMOUNT OF A BLOOD COMPONENT IN THE BLOOD |
CN111239229B (zh) * | 2020-02-24 | 2023-04-11 | 江苏鱼跃医疗设备股份有限公司 | 一种双通道电化学生物传感器及测量血红素浓度的方法 |
CN114778629B (zh) * | 2022-04-28 | 2023-10-20 | 孟栋栋 | 一种用于医疗内分泌科临床抽血检测装置 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001091512A (ja) * | 1999-07-16 | 2001-04-06 | Matsushita Electric Ind Co Ltd | 血液成分分析装置 |
JP2001249103A (ja) * | 1999-12-27 | 2001-09-14 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP2001527215A (ja) * | 1997-12-22 | 2001-12-25 | ロシュ ダイアグノスティックス コーポレーション | 生物学的流体の医学的に有意な成分の濃度を測定する装置および方法 |
JP2003501627A (ja) | 1999-06-02 | 2003-01-14 | ノヴァ バイオメディカル コーポレイション | 使い捨てセンサ及び製造方法 |
JP3369183B2 (ja) | 1993-06-03 | 2003-01-20 | ロシュ・ダイアグノスティックス・コーポレイション | ヘマトクリット決定のためのバイオセンサ |
WO2003008956A1 (fr) * | 2001-07-18 | 2003-01-30 | Arkray, Inc. | Appareil et dispositif pour analyse |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3922598A (en) * | 1974-08-15 | 1975-11-25 | Robert R Steuer | Hematocrit measurements by electrical conductivity |
DE3627814A1 (de) * | 1986-08-16 | 1988-02-25 | Fresenius Ag | Vorrichtung zur bestimmung des haematokrit |
US4897162A (en) * | 1986-11-14 | 1990-01-30 | The Cleveland Clinic Foundation | Pulse voltammetry |
JP2665806B2 (ja) | 1989-09-13 | 1997-10-22 | 株式会社豊田中央研究所 | ヘマトクリット測定装置 |
US5463435A (en) * | 1990-02-09 | 1995-10-31 | Nikon Corporation | Camera |
JP3321734B2 (ja) | 1990-02-09 | 2002-09-09 | 株式会社ニコン | フイルムパトローネおよびこのフイルムパトローネを装填可能な装置 |
US5475454A (en) * | 1990-02-09 | 1995-12-12 | Nikon Corporation | Film magazine and camera |
US5264103A (en) * | 1991-10-18 | 1993-11-23 | Matsushita Electric Industrial Co., Ltd. | Biosensor and a method for measuring a concentration of a substrate in a sample |
JP2960265B2 (ja) * | 1991-10-18 | 1999-10-06 | 松下電器産業株式会社 | バイオセンサおよびそれを用いた測定方法 |
JP2658769B2 (ja) * | 1991-10-21 | 1997-09-30 | 松下電器産業株式会社 | バイオセンサ |
US5582697A (en) * | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
CN1244779A (zh) * | 1995-04-20 | 2000-02-16 | 麦克考股份有限公司 | 非侵入地确定血球比率的方法和设备 |
US6058934A (en) | 1995-11-02 | 2000-05-09 | Chiron Diagnostics Corporation | Planar hematocrit sensor incorporating a seven-electrode conductivity measurement cell |
US6632349B1 (en) * | 1996-11-15 | 2003-10-14 | Lifescan, Inc. | Hemoglobin sensor |
JP3810534B2 (ja) | 1997-10-17 | 2006-08-16 | 松下電器産業株式会社 | ヘマトクリット値測定用素子およびヘマトクリット値の測定方法 |
US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
US7494816B2 (en) * | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
JP3848993B2 (ja) | 1998-01-06 | 2006-11-22 | アークレイ株式会社 | 共存物質の存在下における成分量の測定方法及び測定装置 |
JP3267933B2 (ja) | 1998-01-27 | 2002-03-25 | 松下電器産業株式会社 | 基質の定量法 |
EP0987544B1 (en) * | 1998-04-02 | 2007-10-17 | Matsushita Electric Industrial Co., Ltd. | Substrate determining method |
JP2000039416A (ja) | 1998-05-21 | 2000-02-08 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP3267936B2 (ja) * | 1998-08-26 | 2002-03-25 | 松下電器産業株式会社 | バイオセンサ |
US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
US6471839B1 (en) * | 1999-05-20 | 2002-10-29 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
US6741839B1 (en) * | 1999-09-16 | 2004-05-25 | Samsung Electronics Co., Ltd. | System and method for monitoring adjacent channel power in a wireless base station |
US6616819B1 (en) * | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
CN100347537C (zh) * | 1999-11-15 | 2007-11-07 | 松下电器产业株式会社 | 生物传感器 |
US6541216B1 (en) * | 1999-12-22 | 2003-04-01 | Roche Diagnostics Corporation | Amperometric biosensor test strip |
DE60019547T2 (de) * | 1999-12-27 | 2005-10-06 | Matsushita Electric Industrial Co., Ltd., Kadoma | Biosensor |
JP2001201479A (ja) * | 2000-01-21 | 2001-07-27 | Matsushita Electric Ind Co Ltd | バイオセンサ |
JP4522528B2 (ja) | 2000-03-02 | 2010-08-11 | 文代 楠 | 潰瘍性大腸疾患測定電極、潰瘍性大腸疾患測定装置及び潰瘍性大腸疾患判定方法 |
RU2002128607A (ru) * | 2000-03-22 | 2004-03-20 | Олл Медикус Ко., Лтд. (Kr) | Испытательная полоска электрохимического биодатчика с распознающим электродом, считывающее устройство электрохимического биодатчика, в котором используется эта испытательная полоска, система электрохимического биодатчика и способ работы считывающего устройства электрохимического биодатчика |
CN1187610C (zh) * | 2000-03-29 | 2005-02-02 | 松下电器产业株式会社 | 生物传感器 |
EP1167538A1 (de) * | 2000-06-30 | 2002-01-02 | Schibli Engineering GmbH | Biosensor und Herstellverfahren dafür |
JP2002017186A (ja) * | 2000-06-30 | 2002-01-22 | Hayashibara Biochem Lab Inc | トランスジェニック植物 |
US6444115B1 (en) * | 2000-07-14 | 2002-09-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
JP2002057767A (ja) | 2000-08-08 | 2002-02-22 | Denso Corp | 電話器 |
US20030082076A1 (en) * | 2000-09-01 | 2003-05-01 | Yueh-Hui Lin | Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application |
TW466344B (en) * | 2000-09-01 | 2001-12-01 | Apex Biotechnology Corp | Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application thereof |
CN100510732C (zh) * | 2000-11-30 | 2009-07-08 | 松下电器产业株式会社 | 生物传感器、生物传感器用测量装置 |
JP4183902B2 (ja) * | 2000-12-27 | 2008-11-19 | 松下電器産業株式会社 | バイオセンサ |
US7267750B2 (en) * | 2001-01-17 | 2007-09-11 | Matsushita Electric Industrial Co., Ltd. | Biosensor |
WO2002097418A1 (fr) * | 2001-05-29 | 2002-12-05 | Matsushita Electric Industrial Co., Ltd. | Biodetecteur |
WO2003034055A1 (fr) * | 2001-10-12 | 2003-04-24 | Arkray, Inc. | Procede de mesure de concentration et dispositif de mesure de concentration |
US7018843B2 (en) * | 2001-11-07 | 2006-03-28 | Roche Diagnostics Operations, Inc. | Instrument |
JPWO2003076919A1 (ja) | 2002-03-08 | 2005-07-07 | 松下電器産業株式会社 | 基質の定量方法 |
CN2528010Y (zh) * | 2002-04-02 | 2002-12-25 | 泰博科技股份有限公司 | 生物感测器装置 |
US6837976B2 (en) | 2002-04-19 | 2005-01-04 | Nova Biomedical Corporation | Disposable sensor with enhanced sample port inlet |
AU2003248095A1 (en) * | 2002-07-25 | 2004-02-16 | Arkray, Inc. | Sample analyzing method and sample analyzing device |
AU2003234944A1 (en) * | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
JP2004117342A (ja) | 2002-09-03 | 2004-04-15 | Matsushita Electric Ind Co Ltd | バイオセンサ及びそれを用いた測定法 |
EP1396717A1 (en) * | 2002-09-03 | 2004-03-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor and measuring method using the same |
US7144485B2 (en) * | 2003-01-13 | 2006-12-05 | Hmd Biomedical Inc. | Strips for analyzing samples |
CN1305053C (zh) * | 2003-04-28 | 2007-03-14 | 株式会社三协精机制作所 | 光学头装置及光学头装置用物镜 |
PL1642124T3 (pl) * | 2003-06-20 | 2018-04-30 | F.Hoffmann-La Roche Ag | Biosensory elektrochemiczne |
JP4458802B2 (ja) * | 2003-10-02 | 2010-04-28 | パナソニック株式会社 | 血液中のグルコースの測定方法およびそれに用いるセンサ |
CA2543010A1 (en) | 2003-10-24 | 2005-05-06 | Bayer Healthcare Llc | Enzymatic electrochemical biosensor |
CA2544424A1 (en) * | 2003-10-31 | 2005-05-19 | Lifescan Scotland Limited | Electrochemical test strip for reducing the effect of direct interference current |
JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
WO2005054839A1 (ja) * | 2003-12-04 | 2005-06-16 | Matsushita Electric Industrial Co., Ltd. | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 |
CN100472210C (zh) | 2003-12-04 | 2009-03-25 | 松下电器产业株式会社 | 血液成分的测定方法及该方法中使用的传感器和测定装置 |
WO2005103669A1 (ja) * | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
-
2004
- 2004-12-03 CN CNB2004800355821A patent/CN100472210C/zh active Active
- 2004-12-03 US US10/578,275 patent/US8535497B2/en active Active
- 2004-12-03 EP EP17211212.0A patent/EP3399047A1/en not_active Withdrawn
- 2004-12-03 WO PCT/JP2004/018020 patent/WO2005054840A1/ja active Application Filing
- 2004-12-03 CA CA2548440A patent/CA2548440C/en active Active
- 2004-12-03 EP EP17185406.0A patent/EP3273232A2/en not_active Withdrawn
- 2004-12-03 JP JP2005515983A patent/JP4611208B2/ja active Active
- 2004-12-03 EP EP04819924.4A patent/EP1691192B1/en active Active
- 2004-12-03 EP EP12190642.4A patent/EP2579031B1/en active Active
-
2006
- 2006-06-08 KR KR1020067011240A patent/KR101117332B1/ko active IP Right Grant
-
2010
- 2010-07-01 US US12/829,077 patent/US8540864B2/en active Active
-
2013
- 2013-08-21 US US13/972,389 patent/US9213012B2/en active Active
-
2015
- 2015-11-12 US US14/939,281 patent/US9719956B2/en active Active
-
2017
- 2017-06-27 US US15/634,548 patent/US20170292929A1/en not_active Abandoned
-
2018
- 2018-01-02 US US15/860,190 patent/US20180128769A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3369183B2 (ja) | 1993-06-03 | 2003-01-20 | ロシュ・ダイアグノスティックス・コーポレイション | ヘマトクリット決定のためのバイオセンサ |
JP2001527215A (ja) * | 1997-12-22 | 2001-12-25 | ロシュ ダイアグノスティックス コーポレーション | 生物学的流体の医学的に有意な成分の濃度を測定する装置および方法 |
JP2003501627A (ja) | 1999-06-02 | 2003-01-14 | ノヴァ バイオメディカル コーポレイション | 使い捨てセンサ及び製造方法 |
JP2001091512A (ja) * | 1999-07-16 | 2001-04-06 | Matsushita Electric Ind Co Ltd | 血液成分分析装置 |
JP2001249103A (ja) * | 1999-12-27 | 2001-09-14 | Matsushita Electric Ind Co Ltd | バイオセンサ |
WO2003008956A1 (fr) * | 2001-07-18 | 2003-01-30 | Arkray, Inc. | Appareil et dispositif pour analyse |
Non-Patent Citations (2)
Title |
---|
See also references of EP1691192A4 * |
VARLAN A.R. ET AL: "New design technique for planar conductometric haematocrit sensors", SENSORS AND ACTUATORS, vol. 34, no. 1, August 1996 (1996-08-01), pages 258 - 264, XP000641663 * |
Cited By (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11419532B2 (en) | 2005-06-13 | 2022-08-23 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
EP1746413A2 (en) | 2005-07-19 | 2007-01-24 | Hypoguard Limited | Electrochemical Biosensor and method of manufacture |
EP1746413A3 (en) * | 2005-07-19 | 2007-02-21 | Hypoguard Limited | Electrochemical Biosensor and method of manufacture |
US8430999B2 (en) * | 2005-09-02 | 2013-04-30 | Arkray, Inc. | Method for detecting sample supply condition, and analyzer |
EP2916126A1 (en) * | 2005-09-02 | 2015-09-09 | ARKRAY, Inc. | Analytical tool for for detecting sample supply condition |
JP2009510405A (ja) * | 2005-09-27 | 2009-03-12 | アボット ダイアベティス ケア インコーポレイテッド | インビトロ被検体センサおよびその使用方法 |
JP2018185325A (ja) * | 2005-09-30 | 2018-11-22 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | ゲート化ボルタンメトリー |
US10842427B2 (en) | 2005-09-30 | 2020-11-24 | Intuity Medical, Inc. | Body fluid sampling arrangements |
JP2015052608A (ja) * | 2005-09-30 | 2015-03-19 | バイエル・ヘルスケア・エルエルシー | ゲート化ボルタンメトリー |
JP2020197526A (ja) * | 2005-09-30 | 2020-12-10 | バイエル・ヘルスケア・エルエルシーBayer HealthCare LLC | ゲート化ボルタンメトリー |
US8057404B2 (en) | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
WO2007120149A1 (en) * | 2006-04-18 | 2007-10-25 | Home Diagnostics, Inc. | Biosensors comprising heat sealable spacer materials |
EP2017608A1 (en) * | 2006-04-19 | 2009-01-21 | Panasonic Corporation | Biosensor |
CN101427128B (zh) * | 2006-04-19 | 2013-12-04 | 松下电器产业株式会社 | 生物传感器 |
CN101427128A (zh) * | 2006-04-19 | 2009-05-06 | 松下电器产业株式会社 | 生物传感器 |
JP2013224971A (ja) * | 2006-04-19 | 2013-10-31 | Panasonic Corp | バイオセンサ |
JPWO2007123178A1 (ja) * | 2006-04-19 | 2009-09-03 | パナソニック株式会社 | バイオセンサ |
JP5325574B2 (ja) * | 2006-04-19 | 2013-10-23 | パナソニック株式会社 | バイオセンサ |
KR101139104B1 (ko) | 2006-04-19 | 2012-04-30 | 파나소닉 주식회사 | 바이오센서 |
JP2013156278A (ja) * | 2006-04-19 | 2013-08-15 | Panasonic Corp | バイオセンサ |
EP2017608A4 (en) * | 2006-04-19 | 2012-12-12 | Panasonic Corp | BIOSENSOR |
JP5489092B2 (ja) * | 2006-04-19 | 2014-05-14 | パナソニックヘルスケア株式会社 | バイオセンサ |
WO2007123179A1 (ja) * | 2006-04-19 | 2007-11-01 | Panasonic Corporation | バイオセンサ |
US8945369B2 (en) | 2006-07-26 | 2015-02-03 | Panasonic Healthcare Co., Ltd. | Biosensor measurement system and measurement method |
JP5239860B2 (ja) * | 2006-07-26 | 2013-07-17 | パナソニック株式会社 | バイオセンサ測定システム、および測定方法 |
WO2008013224A1 (fr) * | 2006-07-26 | 2008-01-31 | Panasonic Corporation | Système de mesure de biocapteur et procédé de mesure |
KR101096898B1 (ko) * | 2006-07-26 | 2011-12-22 | 파나소닉 주식회사 | 바이오 센서 측정 시스템, 및 측정 방법 |
JP2013145243A (ja) * | 2006-09-22 | 2013-07-25 | Bayer Healthcare Llc | 改善された安定性およびヘマトクリット性能(performance)を有するバイオセンサー系 |
JP4814953B2 (ja) * | 2006-10-19 | 2011-11-16 | パナソニック株式会社 | 血液試料のヘマトクリット値の測定方法、血液試料中の分析物の濃度の測定方法、センサチップおよびセンサユニット |
US9958411B2 (en) | 2006-10-19 | 2018-05-01 | Panasonic Healthcare Holdings Co., Ltd. | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
US20180217081A1 (en) * | 2006-10-19 | 2018-08-02 | Panasonic Healthcare Holdings Co., Ltd. | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
WO2008047843A1 (en) * | 2006-10-19 | 2008-04-24 | Panasonic Corporation | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
WO2008047842A1 (fr) * | 2006-10-19 | 2008-04-24 | Panasonic Corporation | Procédé de mesure de valeur hématocrite de prélèvement sanguin, procédé de mesure de concentration d'analyte dans un prélèvement sanguin, puce de capteur et unité de détection |
US8691072B2 (en) | 2006-10-19 | 2014-04-08 | Panasonic Corporation | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
CN101529236B (zh) * | 2006-10-19 | 2013-04-03 | 松下电器产业株式会社 | 血样的血细胞比容值的测定方法、血样中的分析物的浓度的测定方法、传感器芯片以及传感器单元 |
US10866205B2 (en) | 2006-10-19 | 2020-12-15 | Phc Holdings Corporation | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
CN101529237B (zh) * | 2006-10-19 | 2012-05-09 | 松下电器产业株式会社 | 血样的血细胞比容值的测定方法、血样中的分析物的浓度的测定方法、传感器芯片以及传感器单元 |
JP4814952B2 (ja) * | 2006-10-19 | 2011-11-16 | パナソニック株式会社 | 血液試料のヘマトクリット値の測定方法、血液試料中の分析物の濃度の測定方法、センサチップおよびセンサユニット |
US9244037B2 (en) | 2006-10-19 | 2016-01-26 | Panasonic Healthcare Holdings Co., Ltd. | Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
US20090038939A1 (en) * | 2007-04-18 | 2009-02-12 | Natasha Popovich | System and methods of chemistry patterning for a multiple well biosensor |
US8460524B2 (en) * | 2007-04-18 | 2013-06-11 | Nipro Diagnostics, Inc. | System and methods of chemistry patterning for a multiple well biosensor |
US10895550B2 (en) | 2007-09-24 | 2021-01-19 | Ascensia Diabetes Care Holdings Ag | Multi-region and potential test sensors, methods, and systems |
US9846136B2 (en) | 2007-09-24 | 2017-12-19 | Ascensia Diabetes Care Holdings Ag | Multi-region and potential test sensors, methods and systems |
US11045125B2 (en) | 2008-05-30 | 2021-06-29 | Intuity Medical, Inc. | Body fluid sampling device-sampling site interface |
US11399744B2 (en) | 2008-06-06 | 2022-08-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
WO2010095442A1 (ja) | 2009-02-18 | 2010-08-26 | パナソニック株式会社 | 穿刺器具、生体試料測定装置及び生体試料測定システム |
US8760178B2 (en) | 2009-09-30 | 2014-06-24 | Arkray, Inc. | Method for measuring target component in erythrocyte-containing specimen |
JP2011075362A (ja) * | 2009-09-30 | 2011-04-14 | Arkray Inc | 赤血球含有試料における目的成分の測定方法 |
US11002743B2 (en) | 2009-11-30 | 2021-05-11 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11933789B2 (en) | 2009-11-30 | 2024-03-19 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11672452B2 (en) | 2011-08-03 | 2023-06-13 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11382544B2 (en) | 2011-08-03 | 2022-07-12 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11051734B2 (en) | 2011-08-03 | 2021-07-06 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
WO2013157263A1 (ja) * | 2012-04-19 | 2013-10-24 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
US9625442B2 (en) | 2012-04-19 | 2017-04-18 | Panasonic Healthcare Holdings Co., Ltd. | Biological information measurement device, and biological information measurement method using same |
US10012610B2 (en) | 2012-04-19 | 2018-07-03 | Phc Holdings Corporation | Biological information measurement device, and biological information measurement method using same |
US9804115B2 (en) | 2012-04-19 | 2017-10-31 | Panasonic Healthcare Holdings Co., Ltd. | Biological information measurement device, and biological information measurement method using same |
JPWO2013157263A1 (ja) * | 2012-04-19 | 2015-12-21 | パナソニックヘルスケアホールディングス株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
JPWO2013168390A1 (ja) * | 2012-05-07 | 2016-01-07 | パナソニックヘルスケアホールディングス株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
WO2013168390A1 (ja) * | 2012-05-07 | 2013-11-14 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
JP5801479B2 (ja) * | 2012-05-07 | 2015-10-28 | パナソニックヘルスケアホールディングス株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
US9629577B2 (en) | 2012-05-07 | 2017-04-25 | Panasonic Healthcare Holdings Co., Ltd. | Biological information measurement device and biological information measurement method using same |
JPWO2013183215A1 (ja) * | 2012-06-06 | 2016-01-28 | パナソニックヘルスケアホールディングス株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
US10107777B2 (en) | 2012-06-06 | 2018-10-23 | Phc Holdings Corporation | Biological information measurement device and biological information measurement method using same |
WO2013183215A1 (ja) * | 2012-06-06 | 2013-12-12 | パナソニック株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
JP5842059B2 (ja) * | 2012-06-06 | 2016-01-13 | パナソニックヘルスケアホールディングス株式会社 | 生体情報測定装置とそれを用いた生体情報測定方法 |
US9410916B2 (en) | 2012-06-06 | 2016-08-09 | Panasonic Healthcare Holdings Co., Ltd. | Biological information measurement device and biological information measurement method using same |
JP2020024221A (ja) * | 2013-03-14 | 2020-02-13 | アセンシア・ディアベティス・ケア・ホールディングス・アーゲー | 保護層を用いた製造中における電極機能の維持 |
JP7002514B2 (ja) | 2013-03-14 | 2022-01-20 | アセンシア・ディアベティス・ケア・ホールディングス・アーゲー | 保護層を用いた製造中における電極機能の維持 |
JP2016510901A (ja) * | 2013-03-14 | 2016-04-11 | バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC | 保護層を用いた製造中における電極機能の維持 |
JP2014232102A (ja) * | 2013-05-02 | 2014-12-11 | アークレイ株式会社 | 測定装置、及び測定方法 |
US10591459B2 (en) | 2013-05-02 | 2020-03-17 | Arkray, Inc. | Measuring apparatus and measuring method |
JPWO2015004900A1 (ja) * | 2013-07-08 | 2017-03-02 | パナソニックヘルスケアホールディングス株式会社 | 血液成分の測定装置、血液成分の測定方法 |
JP2015111115A (ja) * | 2013-11-08 | 2015-06-18 | アークレイ株式会社 | 測定装置、及び測定方法 |
JP2015139376A (ja) * | 2014-01-27 | 2015-08-03 | 東洋紡株式会社 | グルコースデヒドロゲナーゼ組成物 |
US10520460B2 (en) | 2014-10-27 | 2019-12-31 | Lifescan Ip Holdings, Llc | Method for determining diffusion |
JP2017531785A (ja) * | 2014-10-27 | 2017-10-26 | シラグ・ゲーエムベーハー・インターナショナルCilag GMBH International | 拡散を測定するための方法 |
CN104407025A (zh) * | 2014-11-19 | 2015-03-11 | 东莞市青麦田数码科技有限公司 | 一种电化学传感器及其制备方法 |
JP2017009550A (ja) * | 2015-06-26 | 2017-01-12 | 国立研究開発法人産業技術総合研究所 | バイオセンサ |
JP7022728B2 (ja) | 2016-11-25 | 2022-02-18 | Phcホールディングス株式会社 | 生体試料の成分を測定する方法 |
US10996186B2 (en) | 2016-11-25 | 2021-05-04 | Phc Holdings Corporation | Method for measuring components of biological sample |
WO2018097214A1 (ja) * | 2016-11-25 | 2018-05-31 | パナソニックヘルスケアホールディングス株式会社 | 生体試料の成分を測定する方法 |
JP2020073876A (ja) * | 2016-11-25 | 2020-05-14 | Phcホールディングス株式会社 | 生体試料の成分を測定する方法 |
US11635405B2 (en) | 2016-11-25 | 2023-04-25 | Phc Holdings Corporation | Method for measuring components of biological sample |
JPWO2018097214A1 (ja) * | 2016-11-25 | 2019-04-18 | Phcホールディングス株式会社 | 生体試料の成分を測定する方法 |
JP7175129B2 (ja) | 2017-08-17 | 2022-11-18 | アークレイ株式会社 | 測定方法、及び測定装置 |
JP2019035748A (ja) * | 2017-08-17 | 2019-03-07 | アークレイ株式会社 | 測定方法、及び測定装置 |
US10948442B2 (en) | 2017-10-18 | 2021-03-16 | Renesas Electronics Corporation | Impedance measuring semiconductor circuit and blood-sugar level meter |
JP7016152B2 (ja) | 2018-02-21 | 2022-02-04 | 国立研究開発法人産業技術総合研究所 | アッセイ装置 |
JP2019144133A (ja) * | 2018-02-21 | 2019-08-29 | 国立研究開発法人産業技術総合研究所 | アッセイ装置 |
JP2021530695A (ja) * | 2018-07-13 | 2021-11-11 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | マイクロアルブミンクレアチニンアッセイ検出フラグおよびそれに関連する製造および使用方法 |
JP7454547B2 (ja) | 2018-07-13 | 2024-03-22 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | マイクロアルブミンクレアチニンアッセイ検出フラグおよびそれに関連する製造および使用方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1691192B1 (en) | 2015-07-01 |
CN100472210C (zh) | 2009-03-25 |
EP1691192A1 (en) | 2006-08-16 |
EP2579031B1 (en) | 2017-09-27 |
KR20060133989A (ko) | 2006-12-27 |
US20170292929A1 (en) | 2017-10-12 |
EP3399047A1 (en) | 2018-11-07 |
JPWO2005054840A1 (ja) | 2007-06-28 |
JP4611208B2 (ja) | 2011-01-12 |
US20180128769A1 (en) | 2018-05-10 |
US8540864B2 (en) | 2013-09-24 |
US8535497B2 (en) | 2013-09-17 |
EP2579031A1 (en) | 2013-04-10 |
EP1691192A4 (en) | 2009-12-23 |
US20140158553A1 (en) | 2014-06-12 |
US9719956B2 (en) | 2017-08-01 |
EP3273232A2 (en) | 2018-01-24 |
US20070131565A1 (en) | 2007-06-14 |
US20160077040A1 (en) | 2016-03-17 |
CA2548440A1 (en) | 2005-06-16 |
KR101117332B1 (ko) | 2012-03-05 |
US9213012B2 (en) | 2015-12-15 |
CA2548440C (en) | 2016-01-12 |
CN1886651A (zh) | 2006-12-27 |
US20100270177A1 (en) | 2010-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9719956B2 (en) | Method of measuring blood component, sensor used in the method, and measuring device | |
CA2559297C (en) | Method for measuring blood components and biosensor and measuring instrument for use therein | |
JP4717636B2 (ja) | ヘマトクリット(Hct)の測定方法およびそれに用いるセンサならびに測定装置 | |
EP3076167B1 (en) | Method of measuring blood component amount |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480035582.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005515983 Country of ref document: JP |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007131565 Country of ref document: US Ref document number: 10578275 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2548440 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004819924 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067011240 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004819924 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067011240 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10578275 Country of ref document: US |